by | May 21, 2024 | Uncategorized
By Jean Smith-Gonnell and Michael Lafleur The impending reclassification of cannabis to a Schedule III drug under the Controlled Substances Act could have implications for the entire cannabis industry. There… The post Cannabis Rescheduling: A Potential Watershed...
by | May 21, 2024 | Uncategorized
By: Paul Dunford, Co-Founder & VP of Knowledge at Green Check As the cannabis industry continues to grow, financial institutions are increasingly exploring opportunities to bank cannabis-related businesses (CRBs). Engaging… The post Building and Running a...
by | May 20, 2024 | Uncategorized
By Hilary Bricken, Attorney at Husch Blackwell On May 16, the Drug Enforcement Administration (“DEA“) published its 92-page notice of proposed rulemaking (“NPRM“) to move marijuana from schedule 1 on… The post Schedule 3 Marijuana Alert: DEA Publishes NPRM appeared...
by | May 20, 2024 | Uncategorized
Ohio medical marijuana companies are gearing up to begin the process of entering the recreational marijuana business. The Joint Committee on Agency Rule Review (JCARR) recently approved regulations from the Division of Cannabis… The post Ohio medical marijuana...
by | May 19, 2024 | Uncategorized
Potential military recruits and prospective officers soon may not need to worry about drug testing if they recently used marijuana. A provision included in the draft text of a must-pass… The post Marijuana Testing for Recruits Could End Under House’s Must-Pass Defense...
by | May 19, 2024 | Uncategorized
Marijuana business owners hoping to benefit from the Biden administration’s move to reschedule the drug may be in for disappointment, according to experts. The administration announced plans Thursday to move forward with… The post Marijuana rescheduling moves...
Recent Comments